The content on this site is intended for healthcare professionals only
ASCO 2011: Key head and neck cancer research
High dose chemotherapy helps combat neuroblastoma
ASCO 2011 highlights
Autologous stem cell transplantation
Heterogeneity of tumours influences treatment
Partial breast irradiation
Image-guided radiotherapy for liver metastases spares healthy liver
Risks of radiation treatment
Impact of waiting times in head and neck cancer
President-elect of ESTRO
Important factors influencing the treatment of head and neck cancer
Adapting radiotherapy in response to changes in tumour size
